C09BB02 • enalapril + lercanidipine • Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers
The combination of Enalaprilum + Lercanidipinum is used for the treatment of essential hypertension in patients requiring combination therapy. It combines an angiotensin-converting enzyme (ACE) inhibitor (enalaprilum) with a calcium channel blocker (lercanidipinum) to lower blood pressure.
The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart attack.
Side effects may include dizziness, headache, peripheral edema, dry cough, or nausea. It is important to monitor blood pressure and kidney function during treatment.
Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.
Substance: enalapril + lercanidipine
Date of last drug list: 01-01-2015
Commercial code: W61014011
Concentration: 20mg / 20mg
Pharmaceutical form: tablets
Quantity: 100
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. - ITALIA
Holder: RECORDATI IRELAND LIMITED - IRLANDA
Number: 11506/2019/11
Shelf life: 2 years